Many people undoubtedly mention the health benefits of the red wine. But a new Italian study found that the antioxidant-rich drink does not have a substantial influence on inflammation, cardiovascular disease, cancer, or longevity, the Medical Daily reported.

That’s the conclusion a group of researchers came to after observing the effects of the polyphenol antioxidant resveratrol on a group of almost 800 seniors, ages 65 and up. Resveratrol, which can be found in red grape skin, peanuts, cranberries, chocolate, and some Asiatic plant roots, has been studied tirelessly for its health benefits — and a reason to drink more, presumably. Studies have suggested that it can increase levels of high-density lipoprotein (HDL), or the “good” cholesterol, while lowering levels of low-density lipoprotein (LDL), the “bad” cholesterol. And others have shown a link between drinking wine and a lower risk of type 2 diabetes.

The researchers looked at the incidence of disease and death among a large group of seniors living in the winemaking Chianti region of Italy. They assessed their diets and alcohol consumption, and tested urine samples for resveratrol metabolites every three years for nine years. At the nine-year follow-up, they found that 268 patients had died. Of the 629 patients who didn’t have heart disease at the beginning, 174 developed it nine years later. And of the 734 who didn’t have cancer at the start of the study, 34 developed it at the nine-year mark. They also found that, for the most part, those who had more resveratrol in their urine also had the highest incidences of cardiovascular disease and cancer.